Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.
<h4>Background</h4>The associations between obesity, hypertension and diabetes are well established, and the renin-angiotensin system (RAS) may provide a link among them. The effect of RAS inhibition on type 2 diabetes is still unclear; however, RAS seems to play an important role in the...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/155b6bcff49e435d88479510422226cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:155b6bcff49e435d88479510422226cd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:155b6bcff49e435d88479510422226cd2021-11-18T09:03:42ZRenin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice.1932-620310.1371/journal.pone.0067192https://doaj.org/article/155b6bcff49e435d88479510422226cd2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23894285/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The associations between obesity, hypertension and diabetes are well established, and the renin-angiotensin system (RAS) may provide a link among them. The effect of RAS inhibition on type 2 diabetes is still unclear; however, RAS seems to play an important role in the regulation of the pancreas and glucose intolerance of mice fed high-fat (HF) diet.<h4>Methods</h4>C57BL/6 mice fed a HF diet (8 weeks) were treated with aliskiren (50 mg/kg/day), enalapril (30 mg/kg/day) or losartan (10 mg/kg/day) for 6 weeks, and the protective effects were extensively compared among groups by morphometry, stereological tools, immunostaining, Western blotting and hormonal analysis.<h4>Results</h4>All RAS inhibitors significantly attenuated the increased blood pressure in mice fed a HF diet. Treatment with enalapril, but not aliskiren or losartan, significantly attenuated body mass (BM) gain, glucose intolerance and insulin resistance, improved the alpha and beta cell mass and prevented the reduction of plasma adiponectin. Furthermore, enalapril treatment improved the protein expression of the pancreatic islet Pdx1, GLUT2, ACE2 and Mas receptors. Losartan treatment showed the greatest AT2R expression.<h4>Conclusion</h4>Our findings indicate that ACE inhibition with enalapril attenuated several of the deleterious effects of the HF diet. In summary, enalapril appears to be responsible for the normalization of islet morphology and function, of alpha and beta cell mass and of Pdx1 and GLUT2 expression. These protective effects of enalapril were attributed, primarily, to the reduction in body mass gain and food intake and the enhancement of the ACE2/Ang (1-7) /Mas receptor axis and adiponectin levels.Eliete Dalla Corte FrantzCamila Crespo-MascarenhasAndre Rodrigues C Barreto-ViannaMarcia Barbosa AguilaCarlos Alberto Mandarim-de-LacerdaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e67192 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Eliete Dalla Corte Frantz Camila Crespo-Mascarenhas Andre Rodrigues C Barreto-Vianna Marcia Barbosa Aguila Carlos Alberto Mandarim-de-Lacerda Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice. |
description |
<h4>Background</h4>The associations between obesity, hypertension and diabetes are well established, and the renin-angiotensin system (RAS) may provide a link among them. The effect of RAS inhibition on type 2 diabetes is still unclear; however, RAS seems to play an important role in the regulation of the pancreas and glucose intolerance of mice fed high-fat (HF) diet.<h4>Methods</h4>C57BL/6 mice fed a HF diet (8 weeks) were treated with aliskiren (50 mg/kg/day), enalapril (30 mg/kg/day) or losartan (10 mg/kg/day) for 6 weeks, and the protective effects were extensively compared among groups by morphometry, stereological tools, immunostaining, Western blotting and hormonal analysis.<h4>Results</h4>All RAS inhibitors significantly attenuated the increased blood pressure in mice fed a HF diet. Treatment with enalapril, but not aliskiren or losartan, significantly attenuated body mass (BM) gain, glucose intolerance and insulin resistance, improved the alpha and beta cell mass and prevented the reduction of plasma adiponectin. Furthermore, enalapril treatment improved the protein expression of the pancreatic islet Pdx1, GLUT2, ACE2 and Mas receptors. Losartan treatment showed the greatest AT2R expression.<h4>Conclusion</h4>Our findings indicate that ACE inhibition with enalapril attenuated several of the deleterious effects of the HF diet. In summary, enalapril appears to be responsible for the normalization of islet morphology and function, of alpha and beta cell mass and of Pdx1 and GLUT2 expression. These protective effects of enalapril were attributed, primarily, to the reduction in body mass gain and food intake and the enhancement of the ACE2/Ang (1-7) /Mas receptor axis and adiponectin levels. |
format |
article |
author |
Eliete Dalla Corte Frantz Camila Crespo-Mascarenhas Andre Rodrigues C Barreto-Vianna Marcia Barbosa Aguila Carlos Alberto Mandarim-de-Lacerda |
author_facet |
Eliete Dalla Corte Frantz Camila Crespo-Mascarenhas Andre Rodrigues C Barreto-Vianna Marcia Barbosa Aguila Carlos Alberto Mandarim-de-Lacerda |
author_sort |
Eliete Dalla Corte Frantz |
title |
Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice. |
title_short |
Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice. |
title_full |
Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice. |
title_fullStr |
Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice. |
title_full_unstemmed |
Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice. |
title_sort |
renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/155b6bcff49e435d88479510422226cd |
work_keys_str_mv |
AT elietedallacortefrantz reninangiotensinsystemblockersprotectpancreaticisletsagainstdietinducedobesityandinsulinresistanceinmice AT camilacrespomascarenhas reninangiotensinsystemblockersprotectpancreaticisletsagainstdietinducedobesityandinsulinresistanceinmice AT andrerodriguescbarretovianna reninangiotensinsystemblockersprotectpancreaticisletsagainstdietinducedobesityandinsulinresistanceinmice AT marciabarbosaaguila reninangiotensinsystemblockersprotectpancreaticisletsagainstdietinducedobesityandinsulinresistanceinmice AT carlosalbertomandarimdelacerda reninangiotensinsystemblockersprotectpancreaticisletsagainstdietinducedobesityandinsulinresistanceinmice |
_version_ |
1718420949276033024 |